Professional Lunch Series: Public Health with Prakash Narayan, PhD., VP of Preclinical Research

Join us for our Professional Lunch Series with Prakash Narayan, PhD., VP of Preclinical Research, to learn more about Prakash’s career trajectory and professional experiences!

About Prakash Narayan:

Prakash Narayan, Ph.D. is the Vice President of Preclinical Research and Principal Investigator, on 27 NIH+DoD+NSF and other grants at Angion Biomedica Corp., where he oversees drug discovery and developmental activities at Angion’s research and development site. In addition, Dr. Narayan has also served as a mentor for STEM students, dedicating much of his time to helping science research students succeed in their research endeavors.

More on Angion:

Angion is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.

The Angion team is dedicated to bringing new therapeutic options to patients. Our initial focus is acute kidney injury and acute lung injury, where there are currently no pharmacologic therapies available, and chronic fibrotic conditions in the lung and kidney where effective treatments with more limited off-target toxicities are needed.